Interventional Oncology SolutionsMarket Regional Analysis:-
North America is expected to holddominant position in the global InterventionalOncology Solutions Market over the forecast period. This is owing toincreasing mergers & acquisition and research collaboration betweenmanufacturers and universities in the region to develop novel products. Forinstance, in 2015, Boston Scientific enhanced its interventional oncologyportfolio by acquiring spherical embolic technologies, Embozene and Oncozenemicrospheres, which were developed by Celo Nova Biosciences. These spheres aredesigned to prevent flow of blood to the targeted tissue and also reduce growthof tumors. Moreover, in 2016, Philips collaborated with Yale School of Medicineto bring new innovations in the field of interventional oncology. Liver canceris one of their main focus areas, as TACE (Trans arterial Chemoembolization),an alternative and minimally invasive technique to treat liver cancer patients,it has shown better results than chemotherapy. TACE is a minimally invasiveprocedure which is performed in interventional radiology to restrict a tumorsblood supply. Small embolic particles which are coated with chemotherapeuticdrugs are injected through a catheter into the arteries which supply blood tothe tumor. Chemotherapeutic drugs block the supply of blood and inducecytotoxicity i.e. attacking the tumor in several ways. TACE involves administrationof embolic beads and chemotherapy agents to gradually block arteries feedingthe tumor, which further causes death of the tumor.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1884
Interventional oncology is afield of medical science, which includes treatment and diagnosis of cancer andother problems related to cancer using minimally invasive procedures.Interventional oncology uses various techniques such as Ultrasound, computedtomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors locatedin various organs of the body. Interventional oncology procedures are usuallyused to treat metastatic or primary cancer. These procedures can be used totreat cancer in pancreas, liver, lung, breast, prostrate, kidney, and bones.Interventional oncology procedures are segmented into two procedures i.e.diagnostic and therapeutic. Therapeutic procedures can be further categorizedinto ablation techniques and embolization techniques. Ablation techniques usessome form of heat to destroy tumor. Embolization Technique occludes bloodvessels, which feed tumors and further destroy the tumor by means of ischemia.Both these procedures are minimally invasive and there is minimal pain,complications, and discomfort with rapid recovery.
Interventional Oncology SolutionsMarket Drivers:-
Increasing popularity of minimalinvasive procedures due to advantages such as minimal risk of infection,shorter stay in the hospitals, minimal complications, minimal pain, and fasterrecovery as compared to invasive surgeries, is a major factor supporting theglobal interventional oncology solutions market growth over the forecastperiod. Moreover, increasing product launches is expected to aid in growth ininterventional oncology solutions market size. For instance, in 2017, TerumoCorporation, a Japan-based company, launched Quirem Spheres microspheres. Thisis used to treat solid liver tumors, which cannot be removed by surgerycompletely. Microspheres consists of a radioactive isotope Holium-166. QuiremSpheres and can also be visualized in low concentrations by means of SPECT(Single Photon Emission Computed Tomography) and MRI. This feature allowsdoctors to carefully assess distribution of microspheres in the organs such asliver, which enables in accurate assessment of treatment after SIRT (SelectiveInternal radiation Therapy) procedure. Half-life of Quirem Spheres is 26.8hours, which means that within the first 4 days more than 90% of the radiationis delivered, which is followed by implantation procedure.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/interventional-oncology-solutions-market-1884
Europe interventional oncologysolutions market is expected to exhibit high growth over the forecast period,owing to high cancer prevalence in the region. According to a study conductedby World Health Organization (WHO) in 2016, Europe has over 753,600 peoplediagnosed with cancer. Furthermore, key players in the region are focusing onlaunching new products, which is another factor supporting growth of themarket. For instance, in 2017, Elekta, a Sweden-based company, launched ElektaUnity MR-linac, which relies on a Philips 1.5 Tesla MRI Machine. During therapysessions, the machine produces diagnostic level image quality. This deviceprovides more precise treatment, which includes targeting of higher doses on sensitiveareas containing multiple organs and also observation of radiation affectingtumor. One of the most important application of this device is the functionalMRI, which helps doctor to observe how the treatment is working on the tumorand it also helps to evaluate the rate of blood flow through the tumor, whichindicates if the tissue is alive or is showing some change due to the therapy.
Interventional Oncology SolutionsMarket Key Players:-
Key players operating in theglobal interventional oncology solutions market include Boston ScientificCorporation, Angio Dynamics, C.R. Bard, Best Medical International, Pfizer,MedWaves, Health Tronics, Sitex, BTG, Merit Medical Systems, Perseon, CookMedical, Accuracy, Vascular Solutions, TERUMO, ALPINION MEDICAL SYSTEMS, Varianmedical, Smith & Nephew, Profound Medical, BOVIE MEDICAL, and BaylisMedical.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1884
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
